About Genes2me
Genes2me is a Healthcare company based in Gurugram (India) founded in 2016 by Ritu Gupta. Personalized healthcare is delivered via genetics and molecular diagnostics. Its Indian entity Genes 2Me Private Limited reported revenue of ₹21.72 Cr. Genes2me offers products and services including NGS Clinical Assays, Point-of-Care RT-PCR Testing, IVD RT-PCR Testing, Nucleic Acid Extraction, and Rapid Test Kits. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.
Company details
Genes2me was founded in 2016 in Gurugram, India, and operates in the personalized healthcare sector. Genetics and molecular diagnostics are utilized to offer services such as non-invasive prenatal screening, genetic oncology, and screenings for disorders including beta-thalassemia and cystic fibrosis. Additional offerings include HPV testing, blood group typing, and general health and wellness assessments for mothers and children.
- Headquarters Gurugram, India
- Founders Ritu Gupta
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website genes2me.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Genes2me Private Limited
- Date of Incorporation 23 Aug, 2019
- Jurisdiction Delhi, India
- Annual Revenue₹21.72 Cr
FY 2025 · -20% YoY
- Net Loss-₹23.1 Lakh
FY 2025 · -1% margin
- EBITDA₹1.91 Cr
FY 2025 · 9% margin
Associated legal entities of Genes2me
Genes2me operates through Genes 2Me Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genes 2Me Private Limited CIN U73200DL2019PTC354174 | Active | 23 Aug 2019 | Delhi, Delhi | ₹21.7 Cr | 70 | 2 | View details |
Products & Services of Genes2me
Genes2me offers a comprehensive portfolio of products and services, including NGS Clinical Assays, Point-of-Care RT-PCR Testing, IVD RT-PCR Testing, Nucleic Acid Extraction, and Rapid Test Kits.
Solutions for sequencing genetic disorders and personalized medicine.
Rapid molecular tests for on-site disease detection.
Kits for accurate virus and pathogen detection in labs.
Products for efficient DNA and RNA extraction processes.
Quick tests for detecting infections like COVID-19.
Apps and channels of Genes2me
its YouTube channel Genes2Me Pvt. Ltd. has 2.8K subscribers and 30 videos.
Videos from Genes2me
The most watched videos on Genes2me's YouTube channel, Genes2Me Pvt. Ltd. (2.8K subscribers). Click a video to play it here.
More on Genes2Me Pvt. Ltd..
Board of directors of Genes 2Me Private Limited (Genes2me)
Genes 2Me Private Limited is the primary company behind Genes2me. The board of Genes 2Me Private Limited currently have 2 directors; the longest-serving is Neeraj Gupta, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Neeraj Gupta DIN 01214836 | Director | 23 Aug 2019 | 7 yrs 2 mo | Genes 2Me Private Limited |
| Ritu Gupta DIN 02078322 | Director | 23 Aug 2019 | 7 yrs 2 mo | Genes 2Me Private Limited |
People of Genes2me
5 people are tracked at Genes2me (3 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
| Co-Founder & COO | Leadership | |
Vikrant Gupta | Head Of Instrumentation & Manufacturing | Leadership |
| Founder & CEO | Leadership | |
Rose Varghese | Junior Scientific Officer | Team |
Deepak Prashar | Human Resources Manager | Team |
Complete people profiles for Genes2me
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Genes2me
Figures of Genes 2Me Private Limited, the primary company behind Genes2me, for FY 2025. Revenue was ₹21.72 Cr (-20% year on year). Net loss was -₹23.1 Lakh (-1% margin). EBITDA was ₹1.91 Cr (9% margin). Revenue has grown at a compounded annual rate of -53% over three years and +38% over five years.
- ₹21.72 CrRevenue · FY 2025 · -20% YoY
- -₹23.1 LakhNet loss · -1% margin
- ₹1.91 CrEBITDA · 9% margin
- ₹1.00 CrPaid-up capital
- 70Employees (provident fund records)
- -53%Revenue CAGR, 3 years
- +38%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Genes 2Me Private Limited are on its company page.
Detailed financial statements for Genes2me
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Genes2me
The website of Genes2me (genes2me.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 23.3% vs previous month
Websites whose visitors overlap most with Genes2me. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
easydna.in | easydna.in | 100% | #2,867,543 | – | |
ithrive.shop | ithrive.shop | 97% | #992,512 | – | |
dromicslabs.com | dromicslabs.com | 97% | #1,981,834 | – | |
| genepowerx.com | 92% | 11.2K | #2,159,870 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genes2me
Complete news archive for Genes2me
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genes2me
Genes2me was founded in 2016.
Genes2me is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
The primary company behind Genes2me, Genes 2Me Private Limited, reported revenue of ₹21.72 Cr for FY 2025, down 20% year on year.
Genes2me was founded in 2016 in Gurugram, India, and operates in the personalized healthcare sector. Genetics and molecular diagnostics are utilized to offer services such as non-invasive prenatal screening, genetic oncology, and screenings for disorders including beta-thalassemia and cystic fibrosis. Additional offerings include HPV testing, blood group typing, and general health and wellness assessments for mothers and children.
Genes2me offers NGS Clinical Assays, Point-of-Care RT-PCR Testing, IVD RT-PCR Testing, Nucleic Acid Extraction, and Rapid Test Kits.
Genes2me operates through Genes 2Me Private Limited.
The legal entities of Genes2me currently have 2 directors, including Neeraj Gupta, Ritu Gupta.